Acute kidney injury (AKI) is one of the most common serious complications for all hospital
admissions, with its incidence increasing among hospitalized patients, particularly those in …

Background Existing epidemiological studies illustrate that proton pump inhibitors (PPIs)
may be related to adverse kidney outcomes. To date, no comprehensive meta-analysis has …

Importance Patients with acute kidney injury (AKI) are at an increased long-term risk of
death. Effective strategies that improve long-term outcomes in patients with AKI are …

Background Acute kidney injury (AKI), as defined by peak increase in serum creatinine, is
independently associated with increased risk of mortality and length of stay. Studies have …

Background Female sex has been included as a risk factor in models developed to predict
the development of AKI. In addition, the commentary to the Kidney Disease Improving Global …

Background: Acute kidney injury (AKI), even if followed by renal recovery, is a risk factor for
the future development of chronic kidney disease (CKD) and end-stage renal disease …

Rationale & Objective Mesoamerican nephropathy (MeN), a form of chronic kidney disease
(CKD) of unknown cause in Central America, affects young individuals working in physically …

Acute kidney injury (AKI) can increase the risk of developing incident chronic kidney disease
(CKD). The severity, frequency and duration of AKI are crucial predictors of poor renal …

Background/Aims: Recurrent acute kidney injury (AKI) is common among patients after a first
hospitalized AKI. However, little is known about the prognosis of recurrent AKI episodes in …

Purpose The objective of this study was to evaluate AKI incidence with concomitant
vancomycin and piperacillin/tazobactam (PTZ) compared to vancomycin and cefepime …